【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets/Categories Covered 12
3.1 Healthcare IT 12
3.1.1 Clinical IT Systems 12
3.2 In Vitro Diagnostics 13
3.2.1 Clinical Chemistry 13
3.2.2 Haematology 13
3.2.3 Histology And Cytology 13
4 Company Snapshot 14
4.1 Key Facts 14
4.2 Company Overview 14
4.3 Financial Performance 14
4.4 SWOT Snapshot 14
4.5 Business Overview 14
4.6 Major Products and Services 16
4.6.1 Overview 16
5 History 17
6 SWOT Analysis 23
6.1 Overview 23
6.2 Sysmex Corporation Strengths 23
6.2.1 Improving Liquidity Reserves 23
6.2.2 Strong Research and Development Activities 23
6.2.3 Diversified Geographic Presence 24
6.3 Sysmex Corporation Weaknesses 24
6.3.1 Poor Resource Management 24
6.3.2 Low Debt to Equity Ratio 24
6.3.3 High Selling, General and Administrative Expenses 25
6.4 Sysmex Corporation Opportunities 25
6.4.1 Strategic Collaborations and Acquisitions 25
6.4.2 Growing In Vitro Diagnostics Market 25
6.4.3 New Product Launches 26
6.5 Sysmex Corporation Threats 26
6.5.1 Changing Diagnostic Market Conditions 26
6.5.2 Currency Fluctuations 26
6.5.3 Procurement of Raw Materials 26
6.5.4 Increasing Competition 26
7 Competitors 28
8 Competitive Landscape 29
8.1 In Vitro Diagnostics (Clinical Chemistry), Global, Market Share (%), 2011 29
8.2 Sysmex Corporation, In Vitro Diagnostics (Clinical Chemistry), by Region, Market Share (2011) 30
8.3 Sysmex Corporation, In Vitro Diagnostics (Clinical Chemistry), by Country, Market Share (2011) 31
8.4 In Vitro Diagnostics (Haematology), Global, Market Share (%), 2011 33
8.5 Sysmex Corporation, In Vitro Diagnostics (Haematology), by Region, Market Share (2011) 35
8.6 Sysmex Corporation, In Vitro Diagnostics (Haematology), by Country, Market Share (2011) 36
8.7 In Vitro Diagnostics (Histology And Cytology), Global, Market Share (%), 2011 38
8.8 Sysmex Corporation, In Vitro Diagnostics (Histology And Cytology), by Region, Market Share (2011) 39
8.9 Sysmex Corporation, In Vitro Diagnostics (Histology And Cytology), by Country, Market Share (2011) 40
8.10 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 42
9 Sysmex Corporation Medical Equipment Market Share Analysis by Category 45
9.1 Sysmex Corporation, Global, Category Revenue Share (2011) 45
9.2 Sysmex Corporation, Asia-Pacific, Category Revenue Share (2011) 47
9.2.1 Sysmex Corporation, Australia, Category Revenue Share (2011) 49
9.2.2 Sysmex Corporation, China, Category Revenue Share (2011) 51
9.2.3 Sysmex Corporation, India, Category Revenue Share (2011) 53
9.2.4 Sysmex Corporation, Japan, Category Revenue Share (2011) 55
9.2.5 Sysmex Corporation, Other Asia-Pacific, Category Revenue Share (2011) 57
9.3 Sysmex Corporation, Europe, Category Revenue Share (2011) 59
9.3.1 Sysmex Corporation, France, Category Revenue Share (2011) 61
9.3.2 Sysmex Corporation, Germany, Category Revenue Share (2011) 63
9.3.3 Sysmex Corporation, Italy, Category Revenue Share (2011) 65
9.3.4 Sysmex Corporation, Spain, Category Revenue Share (2011) 67
9.3.5 Sysmex Corporation, United Kingdom, Category Revenue Share (2011) 69
9.3.6 Sysmex Corporation, Other Europe, Category Revenue Share (2011) 71
9.4 Sysmex Corporation, Middle East and Africa, Category Revenue Share (2011) 73
9.5 Sysmex Corporation, North America, Category Revenue Share (2011) 75
9.5.1 Sysmex Corporation, Canada, Category Revenue Share (2011) 77
9.5.2 Sysmex Corporation, United States, Category Revenue Share (2011) 79
9.6 Sysmex Corporation, South and Central America, Category Revenue Share (2011) 81
9.6.1 Sysmex Corporation, Brazil, Category Revenue Share (2011) 83
9.6.2 Sysmex Corporation, Mexico, Category Revenue Share (2011) 85
9.6.3 Sysmex Corporation, Other South and Central America, Category Revenue Share (2011) 87
10 Key Employees 89
11 Key Employee Biographies 90
12 Company Statement 91
13 Locations And Subsidiaries 92
13.1 Head Office 92
13.2 Other Locations & Subsidiaries 92
14 Financial Deals Landscape 94
14.1 Sysmex Corporation, Deals Volume Summary, 2007 to YTD 2013 94
15 Sysmex Corporation Detailed Deal Summary 96
15.1 Partnerships 96
15.1.1 Epigenomics Enters Into Licensing Agreement With Sysmex 96
15.1.2 Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex 97
15.1.3 Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems 98
15.1.4 Sysmex Extends Distribution Agreement With Roche 99
15.1.5 IPSOGEN Enters Into Distribution Agreement With Sysmex 100
15.1.6 Sysmex Enters Into Co-Development Agreement With ARKRAY 101
15.1.7 Sysmex Enters Into Distribution Agreement With Malvern Instruments 102
15.1.8 Sysmex America Enters Into Exclusive Distribution Agreement With Medica 103
15.1.9 Siemens Healthcare Diagnostics Enters Into Agreement With Sysmex America 104
15.1.10 Sysmex Europe Enters Into An Agreement with AdnaGen 105
15.1.11 Sysmex Enters Into Joint Venture Agreement With Transasia Bio-Medicals 106
15.1.12 Sysmex Forms Joint Venture With bioMerieux 107
15.1.13 Siemens Medical Extends Its Distribution Agreement With Sysmex America 108
15.1.14 Sysmex America Enters Into Co-Marketing Agreement With Bio-Rad Labs 109
15.1.15 Sysmex Corporation Enters Into An Agreement With Biomerieux 110
15.1.16 Sysmex Extends Distribution Agreement With Roche 111
15.1.17 Sysmex Enters Into Co-Marketing Agreement With Roche 112
15.2 Asset Transactions 113
15.2.1 Vision4health Acquires Molis Information System From Sysmex 113
15.3 Acquisition 114
15.3.1 Sysmex Acquires Stake In Sysmex Taiwan, Medical Device Company 114
15.3.2 Sysmex Acquires Goffin Meyvis Analytical & Medical Systems 115
15.3.3 Sysmex Acquires Remaining 25% Stake In Sysmex India, Lab Regents And Instruments Manufacturer 116
15.3.4 Sysmex Acquires Remaining 25% Stake In Sysmex Transasia Bio-Medicals 117
15.3.5 Sysmex Acquires Remaining 49.2% Stake In CNA, Healthcare IT Company 118
16 Recent Developments 119
16.1 Strategy And Business Planning 119
16.1.1 May 10, 2011: Sysmex Announces New Group Mid-Term Management Plan 119
16.1.2 Apr 28, 2011: Sysmex Establishes Subsidiary In Philippines 119
16.1.3 Apr 19, 2011: Sysmex Establishes Subsidiary In Russia 119
16.1.4 Jan 13, 2010: Sysmex Announces Establishment Of Overseas Subsidiary In Spain To Expand Life Science Business 120
16.1.5 Nov 18, 2008: Sysmex Establishes New Affiliate In Dubai 120
16.2 Financial Announcements 121
16.2.1 Feb 05, 2013: Sysmex Reports Revenue Of JPY101.4 Billion For Nine Months Ended December 31, 2012 121
16.2.2 Nov 06, 2012: Sysmex Reports Revenue Of JPY67.2 Billion In H1 Fiscal 2013 122
16.2.3 Aug 02, 2012: Sysmex Reports Revenue Of JPY31.7 Billion In Q1 Fiscal 2013 123
16.2.4 May 09, 2012: Sysmex Reports Revenue Of JPY134.7 Billion In Fiscal 2012 123
16.2.5 Feb 03, 2012: Sysmex Reports Revenue Of JPY96.9 Billion For Nine Months Ended December 31, 2011 124
16.2.6 Nov 07, 2011: Sysmex Reports Revenues Of JPY65.3 Billion In H1 Fiscal 2012 124
16.2.7 Aug 03, 2011: Sysmex Reports Revenues Of JPY30.8 Billion In Q1 Fiscal 2012 125
16.2.8 May 10, 2011: Sysmex Reports Revenues Of JPY124.7 Billion In Fiscal 2011 126
16.2.9 Feb 02, 2011: Sysmex Reports Revenues Of JPY89.7 Billion In Nine Months Ended December 31, 2010 126
16.2.10 Nov 05, 2009: Sysmex Reports Net Income Of JPY4.3 Billion In H1 Fiscal 2010 126
16.2.11 Aug 04, 2009: Sysmex Posts Net Income Of JPY1.1 Billion In Q1 Fiscal 2010 128
16.2.12 May 11, 2009: Sysmex Posts Net Sales Of JPY111.8 Billion For Fiscal 2009 129
16.2.13 Feb 03, 2009: Sysmex Reports Net Income Of JPY4.6 Billion For Nine Months Of Fiscal 2009 130
16.2.14 Nov 05, 2008: Sysmex Reports 1H Fiscal 2009 Results 131
16.2.15 Aug 04, 2008: Sysmex Reports 1Q Fiscal 2009 Results 132
16.2.16 May 08, 2008: Sysmex Reports Fiscal 2008 Results 134
16.2.17 Feb 05, 2008: Sysmex Reports Nine Months Fiscal 2008 Results 135
16.2.18 Nov 08, 2007: Sysmex Reports 1H Fiscal 2007 Results 137
16.2.19 Aug 03, 2007: Sysmex Reports Q1 Fiscal 2007 Results 137
16.2.20 May 10, 2007: Sysmex Reports Fiscal 2006 Results 137
16.2.21 Aug 03, 2006: Sysmex Reports Q1 Fiscal 2006 Results 138
16.3 Corporate Communications 139
16.3.1 May 11, 2009: Sysmex Announce Management Changes 139
16.3.2 Mar 05, 2009: Sysmex Corporation Announces Executive Changes 140
16.3.3 Sep 29, 2008: Sysmex Director Retires 140
16.3.4 Sep 12, 2008: Sysmex Announces Management Appointments 140
16.4 Product News 141
16.4.1 Dec 25, 2012: Sysmex Launches HISCL-5000, New-Model Automated Immunoassay System For Immunochemistry Testing 141
16.4.2 Jul 22, 2011: Sysmex Launches Automated Blood Coagulation Analyzer CS-5100 141
16.4.3 Jan 17, 2005: Sysmex Develops Technology To Diagnose The Risk Of Post-Operative Recurrence Of Early-Stage Cancer 142
16.5 Other Significant Developments 142
16.5.1 Mar 09, 2012: Sysmex Announces Organizational Changes 142
16.5.2 Mar 24, 2009: Sysmex And Siemens Renew Global Agreement 143
16.5.3 Jun 15, 2007: Sysmex Extends Distribution Agreement With Roche 143
17 Appendix 144
17.1 Research Methodology 145
17.2 Secondary Research 145
17.3 Primary Research 145
17.4 Models 146
17.5 Forecasts 146
17.6 Expert Panels 146
17.7 GlobalData Consulting 146
17.8 Currency Conversion 147
17.9 Contact Us 148
17.10 Disclaimer 148
【レポート販売概要】
■ タイトル：Sysmex Corporation：市場シェア分析■ 英文：Sysmex Corporation Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160563
■ 調査対象地域：グローバル
- スマートピルデリバリ・モニタリング・診断の世界市場Medical Technology (MedTech) is poised to benefit greatly from the convergence of Internet of Things (IoT) technologies including machine-to-machine communications, smart micro or nano-sensors, and other IoT components. Smart pills represent a significant area for next generation MedTech diagnostic solutions in which ingestible tablets or capsules embedded with sensor, camera, tracker, or microchi …
- 世界の電力変圧器市場動向（2012-2016）TechNavio's analysts forecast the Global Power Transformer market to grow at a CAGR of 7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand in developing countries. The Global Power Transformer market has also been witnessing an increase in the power generation capacity. However, fluctuating raw material prices could pose a challen …
- 防爆形モーターの世界市場2018-2022About Explosion Proof Motors Explosion proof motors are electric motors that are designed to operate in harsh environments. The construction of modern explosion proof encapsulation prevents vapor, dust, or gas from entering the motor and creating an explosion. Technavio’s analysts forecast the Global Explosion Proof Motors Market to grow at a CAGR of 3.99% during the period 2018-2022. Covered in t …
- Consolidated Edison Company of New York, Inc.：発電所及びSWOT分析2013Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants …
- ソーシャルゲームのグローバル市場動向（2014-2018）About Social Gaming Social gaming refers to the playing of online games on social media platforms, network sites, or within social media applications. It involves playing games with family and friends. Nowadays, most of the games have some social features included in them, which has led to an increase in the number of end-users. Social games gained popularity when the social networking site, Faceb …
- 金属成形・プレス間搬送ロボットの世界市場2018-2022About Metal Forming and Press Tending Robots Metal forming robots perform processes in which flat sheets or metal rods are reshaped by pressing the material beyond its yield strength. On the other hand, press tending robots are used for applications such as part infeed, transfer and racking of press lines. Technavio’s analysts forecast the global metal forming and press tending robots market to gr …
- ディーゼルエンジンの世界市場2016-2020About Diesel Engines The diesel engine is an internal combustion engine in which air is compressed inside the cylinder to ignite the fuel. Two main types of diesel engines are available in the market. They are two-stroke and four-stroke engines. Diesel engines are capable of offering better operational performance, which makes them a preferred choice over petrol engines. The market is expected to …
- Ophthalmology Therapeutics in Major Developed Markets to 2019 – New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination TherapiesOphthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies Summary GBI Research has released its pharma research, "Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies", wh …
- 世界のフラッキング用化学薬品及び流体市場2015The Global Fracking Chemicals And Fluid Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Fracking Chemicals And Fluid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Fracking Chemicals And Fluid market analysis is provided for the international m …
- Worldwide LTE Market Update and Subscription ForecastsThis report and the associated excel database present a market update for LTE cellular network deployments together with LTE subscription forecasts for up to a five year period. Numerical results in the report are presented in a comprehensible graphical style with granularity levels varying from a global level to specific spectrum bands in a country . Figures from the report can be used to track i …
- Narcolepsy：グローバル臨床試験レビューH2, 2013Narcolepsy Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Narcolepsy Global Clinical Trials Review, H2, 2013" provides data on the Narcolepsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Narcolepsy. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 世界の髄膜炎菌ワクチン市場（2014-2018）About Meningococcal Vaccines Meningitis is characterized by the inflammation of the protective lining (meninges) present around the brain and the spinal cord. On the basis of its underlying cause, meningitis can be classified into infectious and non-infectious meningitis. In terms of the type of organism, infectious meningitis can be sub-divided into bacterial meningitis, viral meningitis, fungal …
- 世界の動物健康管理（医療）市場2014：主要企業の戦略的分析This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for: - Major market segments - Key geographic regions Assessmen …
- 世界自動車産業におけるCFD市場動向（2012-2016）TechNavio's analysts forecast the Global Computational Fluid Dynamics (CFD) market in the Automotive industry to grow at a CAGR of 17.88 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need to develop superior and competitive products. The Global CFD market in the Automotive industry has also been witnessing an increasing demand for in …
- 急性冠症候群（Acute Coronary Syndrome）の治療薬開発：グローバル製薬企業動向PharmaPoint: Acute Coronary Syndrome - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Acute Coronary Syndrome - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global …
